Last updated 2026-07-26
- Raised $100k grant, Oct 2018
- Raised $52k grant, Feb 2016
- Raised Seed round, Nov 2017
Total raised
$152K
Last: Grant 2018-11
Stage
Mature
Founded
2016
Headcount
7
HQ
Misgav, Israel
Sector
Health Tech & Life Sciences
About
Augmentiqs is an Israeli startup that develops augmented reality microscopy technology to bring digital pathology capabilities directly to existing microscopes. Their system enhances the microscope with real-time imaging, telepathology, AI integration, and manual slide scanning, enabling pathologists to work more effectively, collaborate remotely, and conduct research. The company aims to provide a cost-effective solution for transitioning to digital pathology by leveraging existing lab infrastructure. Augmentiqs was founded in 2016 by alumni of the digital pathology industry who believed current solutions were not adequately meeting the true needs of pathologists.
Funding history · 3 rounds · $152K total
2018-10
Grant
$100K
2017-11
Seed
Undisclosed
2016-02
Grant
$52K
Headcount over time
From 3 (2018-11) to 2 (2023-12) · -1 (-33%) · 5 points · source: Finder history + radar grounding
Q&A
- What is Augmentiqs' primary business?
- Augmentiqs transforms traditional microscopes into smart, connected devices for digital pathology, enhancing them with real-time imaging, telepathology, AI integration, and manual slide scanning.
- When was Augmentiqs founded?
- Augmentiqs was founded in 2016.
- Where is Augmentiqs headquartered?
- Augmentiqs is headquartered in Misgav, Israel.
- How many employees does Augmentiqs currently have?
- Augmentiqs has 1-10 employees.
- What was Augmentiqs' most recent funding round?
- Augmentiqs received a Grant round in November 2018, with Luminate NY and NextCorps as lead investors.
- What was the total amount raised by Augmentiqs to date?
- Augmentiqs has raised a total of $451,500 USD.
- What kind of partnership did Augmentiqs announce in March 2020?
- In March 2020, Augmentiqs announced a new technical partnership and integration with Inspirata.
- Who are the co-founders of Augmentiqs?
- The co-founders of Augmentiqs are Gabriel Siegel, who also serves as CEO, and Dan Regelman.
Team · 2
Gabriel Siegel
Founder · CEO & Co-Founder
Dan Regelman
Founder · Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Artificial IntelligenceSimulation & ImagingAugmented Reality
Target customers
Healthcare & Life SciencesHealthcareProvidersLaboratoriesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
electro-opticsclinical-datareal-timeimage-processinglaboratoriesaugmented-realitydoctorshospitalsartificial-intelligencemedical-technologiesmedical-devicesdiagnosticspharma-companieshealthcare-providersdigital-healthcareiotdecision-supporttelemedicine
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | augmentiqs.com |
|---|---|
| linkedin.com/company/18101454 | |
| facebook.com/augmentiqs | |
| YouTube | youtube.com/channel/UCuGbNfhq3-BvDYLrolsfo1w |
Identifiers & details
| Legal name | Augmentiqs Medical Ltd. |
|---|---|
| Founded | 2016 |
| Employees (exact) | 7 |
| Offices | Rochester |
Radar intelligence
Patents
| EPO | 1 |
|---|
Publications (Crossref)
| Works | 2 |
|---|
Web history (Wayback)
| Domain | augmentiqs.com |
|---|
Certificate / subdomain footprint
| Subdomains | 11 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515653640 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2017-05-09 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 4 — annual_report (3), violation (1) |
| Registered address | תכלת 1 משגב |
Recent registry events
| Date | Event |
|---|---|
| 2025-09-24 | דו~ח שנתי-הקצאת מניות |
| 2025-09-24 | עדכון הפרה |
| 2025-09-24 | דו~ח שנתי-הסרת בעל תפקיד |
| 2025-09-24 | דו~ח שנתי-שינוי בהוראות בתקנון |